AXIS THERAPEUTICS

Axis Therapeutics is a leading cancer immunotherapy company focused on the development of T cell therapies... Axis Therapeutics is developing cell-based therapies that take advantage of the unique attributes of TCR mediated target recognition. Central to this platform is the ability to identify endogenous TCRs with specificity for a defined tumor antigen and to then enhance the affinity of the TCR to optimize tumor recognition and killing. These High Affinity TCRs can be incorporated into a patient's own T cells, converting the cells into a potent anti-cancer therapy. Preclinical and early clinical findings have indicated this TCR-T cell therapy technology could potentially be an effective treatment for multiple solid tumor types... Axis is a leading cancer immunotherapy company focused on developing T cell therapies to bring an effective immunotherapy to cancer patients around the world.

Also known as: Axis

Primary location: China United States